Patricia A. Bradford is CEO & Chairman +1 at Phio Pharmaceuticals Corp. (PHIO). They have made 3 open-market trades across 1 company since 2026, most recently 2026-09-28.
CIK 1533040
3 open-market purchases totalling $21K since 2026, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PHIO | 764,871 | $678K |
Shares reported on the most recent Form 4, priced at the 2026-09-29 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.